Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06160050 · ClinicalTrials.gov registry record · NA

PRESERVE & CONNECT: Impact Study of the BPC

A NA study of Trauma and Child Maltreatment, sponsored by University of Vermont.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
2
Study locations

NCT06160050: Recruiting NA study of Trauma and Child Maltreatment, sponsored by University of Vermont.

NCT06160050 is a NA study of Trauma and Child Maltreatment that is actively recruiting participants, run by University of Vermont. The registered enrollment target is 240 participants, below the 303-participant average among 56 other Trauma trials with a reported enrollment target (21% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06160050, a NA study of Trauma and Child Maltreatment, is actively recruiting participants, sponsored by University of Vermont.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
2
Study locations

Study Summary

The PRESERVE \& CONNECT project is a multi-site randomized control trial of the Breakthrough Parenting Curriculum: Navigating Trauma Across Generations (BPC) in rural and racially and ethnically diverse communities in Vermont and Connecticut.

Primary Outcome

substantiated reports of child maltreatment as per administrative records

Conditions Studied

Trauma Child Maltreatment

Interventions

  • BEHAVIORAL Breakthrough Parenting Curriculum: Transforming trauma across generations

Study Locations (2)

Connecticut

  • University of Connecticut - Hartford

Vermont

  • University of Vermont - Burlington

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2024-02-01
Est. Completion 2027-09-20
Phase NA
University of Vermont

162 total trials

What NCT06160050 shows while recruiting

NCT06160050 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 303-participant average among 56 other Trauma trials with a reported enrollment target (21% lower).

The record links to 2 conditions, with Trauma appearing as the primary indexed condition, and to 1 intervention - of which Breakthrough Parenting Curriculum: Transforming trauma across generations is the first listed.

NCT06160050 reports a single indexed study location in Connecticut, Vermont.

Frequently Asked Questions

What is clinical trial NCT06160050 about?

NCT06160050 is a clinical study titled "PRESERVE & CONNECT: Impact Study of the BPC". The PRESERVE \& CONNECT project is a multi-site randomized control trial of the Breakthrough Parenting Curriculum: Navigating Trauma Across Generations (BPC) in rural and racially and ethnically diverse communities in Vermont and Connecticut.

What is the current status of trial NCT06160050?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2024-02-01. Estimated completion is 2027-09-20.

What conditions does trial NCT06160050 study?

This clinical trial studies the following conditions: Trauma, Child Maltreatment.

What interventions are being tested in trial NCT06160050?

The interventions under investigation include: Breakthrough Parenting Curriculum: Transforming trauma across generations (BEHAVIORAL).

Who is sponsoring clinical trial NCT06160050?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06160050 being conducted?

This trial has 2 study locations across Connecticut, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06160050's enrollment target sits among peer trials

240 18th of 56 higher than 39 of 56 other Trauma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Trauma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06160050

Source: ClinicalTrials.gov NCT06160050, the US trial registry maintained by the National Library of Medicine. NCT06160050 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.